Clinical Trial Update: A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus [Phase 1, Phase 2]

View source ↗

Summary

A controlled clinical trial investigating an antivenom for Bungarus multicinctus envenoming in Phase 1 and Phase 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Snake Bite

Drugs mentioned

• Bungarus multicinctus antivenom (Bungarus multicinctus antivenom)

Snippet

Sponsor: Hanoi Medical University | Conditions: Snake Bite | Phase 1, Phase 2 | Status: COMPLETED